Interestingly, the reduction in ECM content in response to TNFα‐CSG treatment was positively correlated with immune cell infiltration in the RIP1‐Tag5 tumours (Fig 4C and D), supporting the notion that the immune cell proteases degrade the ECM. Here, TNF is linked to neoplasm.